Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Wadsworth Center, New York State Department of Health, Albany, NY, USA.
J Hum Genet. 2017 Oct;62(10):877-884. doi: 10.1038/jhg.2017.56. Epub 2017 May 25.
Split hand/foot malformation (SHFM) is a congenital limb deficiency with missing or shortened central digits. Some SHFM genes have been identified but the cause of many SHFM cases is unknown. We used single-nucleotide polymorphism (SNP) microarray analysis to detect copy-number variants (CNVs) in 25 SHFM cases without other birth defects from New York State (NYS), prioritized CNVs absent from population CNV databases, and validated these CNVs using quantitative real-time polymerase chain reaction (qPCR). We tested for the validated CNVs in seven cases from Iowa using qPCR, and also sequenced 36 SHFM candidate genes in all the subjects. Seven NYS cases had a potentially deleterious variant: two had a p.R225H or p.R225L mutation in TP63, one had a 17q25 microdeletion, one had a 10q24 microduplication and three had a 17p13.3 microduplication. In addition, one Iowa case had a de novo 10q24 microduplication. The 17q25 microdeletion has not been reported previously in SHFM and included two SHFM candidate genes (SUMO2 and GRB2), while the 10q24 and 17p13.3 CNVs had breakpoints within genomic regions that contained putative regulatory elements and a limb development gene. In SHFM pathogenesis, the microdeletion may cause haploinsufficiency of SHFM genes and/or deletion of their regulatory regions, and the microduplications could disrupt regulatory elements that control transcription of limb development genes.
并指(趾)畸形(SHFM)是一种先天性肢体缺陷,表现为中央指(趾)缺失或缩短。部分 SHFM 相关基因已经被鉴定,但许多 SHFM 病例的病因仍然未知。我们采用单核苷酸多态性(SNP)微阵列分析,对来自纽约州(NYS)的 25 例无其他先天畸形的 SHFM 患者进行拷贝数变异(CNV)检测,优先分析人群 CNV 数据库中不存在的 CNV,并使用实时定量聚合酶链反应(qPCR)对这些 CNV 进行验证。我们采用 qPCR 对来自爱荷华州的 7 例患者进行了验证 CNV 的检测,还对所有研究对象的 36 个 SHFM 候选基因进行了测序。在 7 例 NYS 患者中发现了潜在的致病性变异:2 例患者的 TP63 基因存在 p.R225H 或 p.R225L 突变,1 例患者存在 17q25 微缺失,1 例患者存在 10q24 微重复,3 例患者存在 17p13.3 微重复。此外,1 例爱荷华州患者存在新发的 10q24 微重复。该 17q25 微缺失此前尚未在 SHFM 中报道过,包含 2 个 SHFM 候选基因(SUMO2 和 GRB2),而 10q24 和 17p13.3 的 CNV 断点位于含有潜在调控元件和肢体发育基因的基因组区域内。在 SHFM 发病机制中,微缺失可能导致 SHFM 基因的杂合性缺失和/或其调控区域的缺失,微重复可能破坏调控肢体发育基因转录的调控元件。